首页工具

登录

搜索结果

Search Results for " anti-myeloma "

32

抑制剂 & 化合物

2

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T8719	SC99	Apoptosis; JAK; STAT	Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells
	SC99 是一种口服有效选择性STAT3抑制剂，靶向 JAK2-STAT3 途径，抑制血小板活化和聚集，有抗骨髓瘤和抗血栓活性。它结合在 JAK2 的 ATP 结合袋中，抑制 JAK2 和 STAT3 的磷酸化。
T10981	DCZ0415	Apoptosis; Others; NF-κB	Apoptosis; NF-κB; Others
	DCZ0415 在体外、体内和耐药性骨髓瘤患者的原代细胞中诱导抗骨髓瘤活性。它是一种 TRIP13 抑制剂，可损害非同源末端连接的修复并抑制 NF-κB 活性。
T9918	Daratumumab 达妥木单抗	Others	Others
	Daratumumab 是一种首创的特异性抗CD38单克隆抗体。它损伤了 MM 细胞的粘附，从而增加了 MM 对蛋白酶体抑制的敏感性。它具有抗多发性骨髓瘤(MM) 的作用。
T6800	CCF642 AC1LYELL	Others	Others
	CCF642 (AC1LYELL) 是蛋白质二硫键异构酶抑制剂(IC50:2.9 μM)。它在多发性骨髓瘤细胞中引起急性内质网应激，并伴随凋亡诱导的钙释放，表现出广泛的抗多发性骨髓瘤作用。
T2345	PTC-209 PTC209,PTC 209	BMI-1; Autophagy	Autophagy; Cell Cycle/Checkpoint; DNA Damage/DNA Repair
	PTC-209 是特定的BMI-1抑制剂，不可逆转地损害结直肠癌起始细胞，在 HEK293T 细胞系中的IC50为 0.5 μM。它有抗骨髓瘤活性并损害肿瘤微环境。
T3661	Citarinostat ACY241,HDAC-IN-2	HDAC	Chromatin/Epigenetic; DNA Damage/DNA Repair
	Citarinostat (ACY241) 是一种强效、选择性和口服组蛋白脱乙酰酶 (HDAC) 抑制剂，具有抗肿瘤活性，对 HDAC1、HDAC2、HDAC3、HDAC6 和 HDAC8 的 IC50分别为 35、45、46、2.6 和 137 nM。
T6178	PTC-209 hydrobromide PTC-209 HBr	BMI-1; Autophagy	Autophagy; Cell Cycle/Checkpoint; DNA Damage/DNA Repair
	PTC-209 hydrobromide (PTC-209 HBr) 是一种特定的BMI-1抑制剂，能不可逆转地损害结直肠癌起始细胞，也可损害肿瘤微环境，有抗骨髓瘤活性。它在 HEK293T 细胞系中的IC50为 0.5 μM。
T12644L	(S)-Thalidomide (S)-(-)-Thalidomide	Apoptosis	Apoptosis
	(S)-Thalidomide ((S)-(-)-Thalidomide) 是 Thalidomide 的 S 型异构体，具有免疫调节，抗炎，抗癌，抗血管生成活性和促凋亡活性，可用于研究麻风结节性红斑和骨髓瘤。
T35390	Magrolimab Hu5F9-G4,Magrolimab (anti-CD47)	Others	Others
	Magrolimab (Hu5F9-G4) 是一种人源化抗 CD47 IgG4 单克隆抗体，通过阻断CD47来展现其抗肿瘤活性，主要与CD47的 N 末端焦谷氨酸结合，可用于和其他化合物联合治疗复发性骨髓瘤。
T35386	Elotuzumab Elotuzumab (anti-SLAMF7),BMS 901608,PDL 063,HuLuc 63	Others	Others
	Elotuzumab(HuLuc 63) (anti-SLAMF7) 是一种靶向 SLAMF7 受体的单克隆抗体。Elotuzumab (anti-SLAMF7) 是一种直接激活NK细胞并诱导抗体依赖性细胞毒性的化合物，可联合来那度胺和地塞米松（Ld）用于治疗多发性骨髓瘤。
T11141	E64FC26	Others	Others
	E64FC26 是一种有效的蛋白质二硫键异构酶 (PDI) 家族泛抑制剂，具有抗肿瘤活性，抑制 PDIA1、PDIA3、PDIA4、TXNDC5 和 PDIA6，可用于研究多发性骨髓瘤和胰腺癌。
T76794	Ulocuplumab BMS 936564,MDX 1338	Apoptosis; CXCR	Apoptosis; Autophagy; GPCR/G Protein; Immunology/Inflammation
	Ulocuplumab (BMS-936564) 是一种完全人抗 CXCR4 的 IgG4 抗体。Ulocplumab 在急性髓系白血病 (AML)，非霍奇金淋巴瘤 (NHL) 和多发性骨髓瘤移植模型中展现出抗肿瘤活性。Ulocplumab 对 CXCL12 介导的慢性淋巴细胞白血病 (CLL) 细胞在 CXCR4 激活下的迁移有抑制作用，诱导癌细胞凋亡 (apoptosis)，。
T28805	SLM6 NSC-107517,NSC 107517,Sangivamycin-Like Molecule 6,SLM 6,SLM-6
	SLM6, an inhibitor of cyclin-dependent kinase-9 (CDK9), exhibits potent anti-multiple myeloma activity.
T63906	hGGPPS-IN-2
	hGGPPS-IN-2 是一种 C-2 取代的噻吩并嘧啶基双膦酸盐 (C2-ThP-BPs) 的类似物，是一种有效的人类香叶基香叶基焦磷酸合成酶 (hGGPPS) 抑制剂。hGGPPS-IN-2 能够靶向作用于多发性骨髓瘤 (MM) 细胞，诱导其选择性凋亡 (apoptosis)，并在体内显示出抗骨髓瘤作用。
T73485	BT-GSI
	BT-GSI 是一种 γ-分泌酶抑制剂 (GSI) 和骨靶向 Notch 抑制剂。BT-GSI 具有双重抗骨髓瘤和抗吸收特性，可用于多发性骨髓瘤及相关骨病的研究。BT-GSI 抑制肿瘤生长和溶骨性疾病进展。
T36625	LSD1/HDAC6-IN-1 LSD1/HDAC6-IN-1
	LSD1/HDAC6-IN-1 is an orally active compound that functions as a dual inhibitor, targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6). This compound demonstrates promising anti-tumor activity and is particularly valuable for research focused on multiple myeloma (MM) [1].
T61792	HDAC6-IN-10
	HDAC6-IN-10 is a potent and specific HDAC6 inhibitor, exhibiting an IC50 value of 0.73 nM. It demonstrates remarkable selectivity towards HDAC6, with a selectivity range of 144 to 10,941-fold over other HDAC isoforms. Furthermore, HDAC6-IN-10 exhibits notable anti-proliferative effects on multiple myeloma cells [1].
T39812	(E/Z)-E64FC26 (E/Z)-E64FC26
	(E/Z)-E64FC26 is a mixture complex comprising E-E64FC26 and Z-E64FC26. E-E64FC26 is a highly potent pan-inhibitor of the protein disulfide isomerase (PDI) family, with IC50 values of 1.9, 20.9, 25.9, 16.3, and 25.4 μM against PDIA1, PDIA3, PDIA4, TXNDC5, and PDIA6, respectively. Furthermore, E64FC26 demonstrates anti-myeloma activity.
T77903	Belantamab mafodotin Belantamab mafodotin-blm,GSK2857916
	Belantamab mafodotin (GSK2857916) 为人源化的抗B细胞成熟抗原(BCMA)单克隆抗体与McMMAF共轭物，展现出对骨髓瘤的治疗活性。
T61945	hGGPPS-IN-1
	hGGPPS-IN-1 是 C-2 取代的噻吩并嘧啶基双膦酸盐 (C2-ThP-BPs) 的类似物，对人类香叶基香叶基焦磷酸合成酶 (hGGPPS) 具有有效的抑制作用。hGGPPS-IN-1 可选择性诱导多发性骨髓瘤 (MM) 细胞凋亡 (apoptosis)。hGGPPS-IN-1在体内表现出抗骨髓瘤活性。
T15158	Dolastatin 15 DLS 15	Others	Others
	Dolastatin 15, a depsipeptide derived from Dolabella auricularia, is a potent antimitotic agent structurally related to the anti-tubulin agent Dolastatin 10. Dolastatin 15 can be used as an ADC cytotoxin and it induces cell cycle arrest and apoptosis in m
T76677	Dacetuzumab
	Dacetuzumab (SGN-40) 是一种人源化的 IgG1，抗 CD40单克隆抗体，具有抗淋巴瘤活性。Dacetuzumab 通过免疫效应作用(抗体依赖性细胞毒性和吞噬作用[ADCC/ADCP]) 杀死肿瘤细胞。Dacetuzumab ((SGN-40) 可用于多发性骨髓瘤研究。
T69323	Dexamethasone sodium succinate
	Dexamethasone sodium succinate is the acetate salt form of dexamethasone, which is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. At high doses (e.g. 40 mg), it reduces the immune response. Dexamethasone acetate (NEOFORDEX®) is indicated in adults for the treatment of symptomatic multiple myeloma in combination with other medicinal products. Dexamethasone has been shown to induce multiple myeloma cell death (apoptosis) via a down-regul...
T77091	Modakafusp alfa
	Modakafusp alfa (TAK-573) 是一种融合蛋白，由人源化抗CD38 IgG4 单克隆抗体和2个减毒IFNα2b分子组成。该化合物主要用于多发性骨髓瘤的研究。
T36761	KRAS inhibitor-10
	KRAS inhibitor-10 (WO2021005165 A1, compound 11) is a potent and selective inhibitor of RAS proteins, with a specific focus on KRAS proteins. This orally active anti-cancer agent demonstrates strong efficacy in cancer research, specifically in pancreatic cancer, breast cancer, multiple myeloma, leukemia, and lung cancer. KRAS inhibitor-10 is classified as a tetrahydroisoquinoline compound. Its inhibitory properties provide valuable insights and potential therapeutic applications in the field of ...
T79478	Anti-inflammatory agent 45	Apoptosis	Apoptosis
	Anti-inflammatory agent 45（化合物2v）作为一种抗癌剂，直接抑制多种血癌细胞系（如白血病、淋巴瘤、骨髓瘤）的生长。该化合物能够诱导HL60白血病细胞发生凋亡，并可抑制NO生成，其半抑制浓度（IC50）为14.7 μM。
T61313	Antitumor agent-70
	Antitumor agent-70 (compound 8b) is a highly potent multi-targeted kinase inhibitor, particularly targeting c-Kit. It demonstrates remarkable anti-tumor activity and the ability to induce cell apoptosis. This compound also exhibits strong inhibition of multiple myeloma, with an IC 50 value of 0.12 μM. Therefore, Antitumor agent-70 holds great potential as an effective therapy for combating cancer, especially in cases involving c-Kit. [1]
T76729	Lucatumumab
	Lucatumumab (HCD122) 是一种全人抗 CD40拮抗剂单克隆抗体，可阻断 CD40/ CD40L 介导的信号通路。Lucatumumab 可有效介导抗体依赖性细胞介导的细胞毒性 (ADCC) 和肿瘤细胞清除，可用于顽固性淋巴瘤、慢性淋巴细胞白血病 (CLL) 和多发性骨髓瘤研究。
T79523	HDAC6-IN-18	HDAC	Chromatin/Epigenetic; DNA Damage/DNA Repair
	HDAC6-IN-18（化合物4）是首个针对HDAC6亚型的不可逆选择性抑制剂，显示出有效的抗多发性骨髓瘤活性。该抑制剂在RPMI8266、U266以及MM.1S细胞系中表现出对HDAC6的抑制效力，其IC50值分别为0.17、0.7和0.42 μM[1]。
T69821	AMP423
	AMP423 is a naphthyl derivative of 2-cyanoaziridine-1-carboxamide with structural similarity to the pro-oxidant anti-tumor agent imexon. AMP423 was active in SCID mice bearing 8226/S myeloma and SU-DHL-6 B-cell lymphoma tumors, with a median tumor growth delay (T-C) of 21 days (P = 0.0002) and 5 days (P = 0.004), respectively, and a median tumor growth inhibition (T/C) of 33.3% (P = 0.03) and 82% (P = 0.01), respectively. In non-tumor-bearing mice, AMP423 was not myelosuppressive.
T62907	TAS-117 hydrochloride
	TAS-117 hydrochloride 是一种选择性的、有效的、口服具有活力的别构 Akt 抑制剂，作用于 Akt1 (IC50: 4.8 nM) 、Akt2 (IC50: 1.6 nM) 和 Akt3 (IC50: 44 nM)。TAS-117 hydrochloride 能够激发抗骨髓瘤活性，增强蛋白酶体抑制诱导的致命内质网应激，可以诱导细胞凋亡和自噬。
T77084	Mezagitamab
	Mezagitamab (TAK-079) 是一种 IgG1λ 类型的抗CD38单克隆抗体。其通过促进抗体和补体依赖性的细胞毒性，来耗尽表达CD38的肿瘤细胞，显示出在复发/难治性多发性骨髓瘤 (RRMM) 及原发性血小板减少性紫癜 (ITP) 等疾病中的治疗潜力。

化合物

Cat.No: T8719

Target: Apoptosis, JAK, STAT

Cat.No: T10981

Target: Apoptosis, Others, NF-κB

Cat.No: T9918

Synonym: 达妥木单抗

Target: Others

Cat.No: T6800

Synonym: AC1LYELL

Target: Others

Cat.No: T2345

Synonym: PTC209,PTC 209

Target: BMI-1, Autophagy

Cat.No: T3661

Synonym: ACY241,HDAC-IN-2

Target: HDAC

PTC-209 hydrobromide

Cat.No: T6178

Synonym: PTC-209 HBr

Target: BMI-1, Autophagy

(S)-Thalidomide

Cat.No: T12644L

Synonym: (S)-(-)-Thalidomide

Target: Apoptosis

Cat.No: T35390

Synonym: Hu5F9-G4,Magrolimab (anti-CD47)

Target: Others

Cat.No: T35386

Synonym: Elotuzumab (anti-SLAMF7),BMS 901608,PDL 063,HuLuc 63

Target: Others

Cat.No: T11141

Target: Others

Cat.No: T76794

Synonym: BMS 936564,MDX 1338

Target: Apoptosis, CXCR

Cat.No: T28805

Synonym: NSC-107517,NSC 107517,Sangivamycin-Like Molecule 6,SLM 6,SLM-6

Cat.No: T63906

Cat.No: T73485

LSD1/HDAC6-IN-1

Cat.No: T36625

Synonym: LSD1/HDAC6-IN-1

Cat.No: T61792

Cat.No: T39812

Synonym: (E/Z)-E64FC26

Belantamab mafodotin

Cat.No: T77903

Synonym: Belantamab mafodotin-blm,GSK2857916

Cat.No: T61945

Cat.No: T15158

Synonym: DLS 15

Target: Others

Cat.No: T76677

Dexamethasone sodium succinate

Cat.No: T69323

Modakafusp alfa

Cat.No: T77091

KRAS inhibitor-10

Cat.No: T36761

Anti-inflammatory agent 45

Cat.No: T79478

Target: Apoptosis

Antitumor agent-70

Cat.No: T61313

Cat.No: T76729

Cat.No: T79523

Target: HDAC

Cat.No: T69821

TAS-117 hydrochloride

Cat.No: T62907

Cat.No: T77084

Cat. No.	Product Name	Target	Signaling Pathways
T3398	Icaritin Anhydroicaritin,去水淫羊藿黄素,Cycloicaritin	Apoptosis; JAK; STAT; Autophagy	Angiogenesis; Apoptosis; Autophagy; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells
	Icaritin (Anhydroicaritin) 是Epimedium Genusis 的异戊二烯类黄酮衍生物，有效抑制 K562 细胞和原代 CML 细胞的增殖。它可以调节MAPK/ERK/JNK 和JAK2/STAT3/AKT 信号传导，并具有增强成骨的作用。
TN3870	Iriflophenone 2-O-Rhamnoside Dimethylmatairesinol	Others	Others
	Dimethylmatairesinol can reduce the amount of Immunoglobulin E (IgE) secreted by human myeloma U266 cells, it has potential as an anti-allergic agent. Dimethylmatairesinol also exhibits significant cytotoxicity against three human tumor cells(A-549 lung c

天然产物

Cat.No: T3398

Synonym: Anhydroicaritin,去水淫羊藿黄素,Cycloicaritin

Target: Apoptosis, JAK, STAT, Autophagy

Iriflophenone 2-O-Rhamnoside

Cat.No: TN3870

Synonym: Dimethylmatairesinol

Target: Others

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼